Matthew Shirk, DO | |
1001 S George St York, York, PA 17046 | |
(717) 812-4090 | |
Not Available |
Full Name | Matthew Shirk |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1001 S George St York, York, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184300378 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | OT022567 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Matthew Shirk, DO 1001 S George St York, York, PA 17403 Ph: () - | Matthew Shirk, DO 1001 S George St York, York, PA 17046 Ph: (717) 812-4090 |
News Archive
A new "telerehabilitation" approach lets physical therapists assess patients with low back pain over the Internet, with good accuracy compared with face-to-face examinations, reports a study in the May 15 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton also announced that it will continue to make available branded Timoptic-XE.
More powerful gene-sequencing tools have increasingly been uncovering disease secrets in DNA within the cell nucleus. Now a research team is expanding those rapid next-generation sequencing tests to analyze a separate source of DNA—within the genes inside mitochondria, cellular power plants that, when abnormal, contribute to complex, multisystem diseases.
SemBioSys Genetics Inc., a biotechnology company developing protein pharmaceuticals in crop plants, has announced that it has initiated a phase I/II clinical trial of its plant-produced insulin with the first injection of its drug in humans.
› Verified 1 days ago
Timothy Unger, Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 25 Monument Rd # 250, York, PA 17403 Phone: 717-812-4090 Fax: 717-812-4092 | |
Craig Richard Ruder, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, Suite 290, York, PA 17403 Phone: 717-812-4090 Fax: 717-812-4092 | |
Dr. Jovito Angeles Ii, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 250, York, PA 17403 Phone: 717-812-4090 Fax: 717-812-4092 | |
Dr. Nicole Fraticelli, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd Ste 290, York, PA 17403 Phone: 717-812-4090 Fax: 717-812-4092 | |
Ronald Lakatos, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-741-9867 | |
Dr. Paul Patrick Muccino, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, Suite 290, York, PA 17403 Phone: 717-812-4090 Fax: 717-812-4092 | |
Dr. Matthew William Christian, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1855 Powder Mill Rd, York, PA 17402 Phone: 717-848-4800 Fax: 717-741-9867 |